• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肥胖作为 COVID-19 患者住院的风险因素:托斯卡纳地区数据库分析。

Obesity as a risk factor for hospitalization in COronaVirus Disease-19 (COVID-19) patients: Analysis of the Tuscany regional database.

机构信息

ARS Agenzia Regionale Sanità, Toscana Italy.

Diabetology, Careggi Hospital, Florence, Italy.

出版信息

Nutr Metab Cardiovasc Dis. 2021 Mar 10;31(3):769-773. doi: 10.1016/j.numecd.2020.11.030. Epub 2020 Dec 8.

DOI:10.1016/j.numecd.2020.11.030
PMID:33549434
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7722497/
Abstract

BACKGROUND AND AIMS

Aim of the present study is to determine the role of obesity as a risk factor for COronaVirus Disease-19 (COVID-19) hospitalization.

METHODS AND RESULTS

This observational study was performed using Istituto Superiore di Sanità (ISS) Tuscany COVID-19 database by the Agenzia Regionale Sanità (ARS), including all COVID-19 cases registered until April 30th, 2020, with reported information on chronic diseases. The principal outcome was hospitalization. An age and gender-adjusted logistic regression model was used to assess the association of clinical and demographic characteristics with hospitalization. Further multivariate models were applied. Of 4481 included subjects (36.9% aged over 70 years), 1907 (42.6%) were admitted to hospital. Obesity was associated with hospitalization after adjusting for age and gender. The association of obesity with hospitalization retained statistical significance in a fully adjusted model, including possible confounders (OR: 2.99 [IC 95% 2.04-4.37]). The effect of obesity was more evident in younger (<70 years) than in older (≥70 years) subjects.

CONCLUSIONS

The present data confirm that obesity is associated with an increased risk of hospitalization in patients with COVID-19. Interestingly, the association of obesity with hospitalization was greater in younger (<70 years) patients.

摘要

背景与目的

本研究旨在确定肥胖是否为感染 COVID-19 住院的危险因素。

方法和结果

本观察性研究使用意大利卫生研究所(ISS)托斯卡纳 COVID-19 数据库,由区域卫生局(ARS)进行,包括截至 2020 年 4 月 30 日登记的所有 COVID-19 病例,报告了慢性疾病信息。主要结局是住院。使用年龄和性别调整的逻辑回归模型评估临床和人口统计学特征与住院的相关性。进一步应用多变量模型。在纳入的 4481 例患者中(36.9%年龄超过 70 岁),1907 例(42.6%)住院。在调整年龄和性别后,肥胖与住院相关。在包括可能混杂因素的完全调整模型中,肥胖与住院的相关性仍然具有统计学意义(OR:2.99 [95%CI 2.04-4.37])。肥胖对住院的影响在年龄较小(<70 岁)的患者中比年龄较大(≥70 岁)的患者中更为明显。

结论

本数据证实肥胖与 COVID-19 患者住院风险增加相关。有趣的是,肥胖与住院的相关性在年龄较小(<70 岁)的患者中更大。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee5e/7722497/312efb5afc6a/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee5e/7722497/312efb5afc6a/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee5e/7722497/312efb5afc6a/gr1_lrg.jpg

相似文献

1
Obesity as a risk factor for hospitalization in COronaVirus Disease-19 (COVID-19) patients: Analysis of the Tuscany regional database.肥胖作为 COVID-19 患者住院的风险因素:托斯卡纳地区数据库分析。
Nutr Metab Cardiovasc Dis. 2021 Mar 10;31(3):769-773. doi: 10.1016/j.numecd.2020.11.030. Epub 2020 Dec 8.
2
[Chronic diseases and risk of symptomatic COVID-19: results of a case-population study on a sample of patients in the Local Health Unit 'Toscana Centro' (Tuscany Region, Central Italy)].[慢性病与有症状的2019冠状病毒病风险:对托斯卡纳中心地方卫生单位(意大利中部托斯卡纳大区)患者样本的病例-人群研究结果]
Epidemiol Prev. 2020 Sep-Dec;44(5-6 Suppl 2):308-314. doi: 10.19191/EP20.5-6.S2.131.
3
Nonrespiratory Complications and Obesity in Patients Dying with COVID-19 in Italy.意大利 COVID-19 死亡患者的非呼吸并发症和肥胖问题。
Obesity (Silver Spring). 2021 Jan;29(1):20-23. doi: 10.1002/oby.23007. Epub 2020 Oct 18.
4
Determinants of survival after severe acute respiratory syndrome coronavirus 2 infection in Mexican outpatients and hospitalised patients.墨西哥门诊和住院患者严重急性呼吸综合征冠状病毒 2 感染后生存的决定因素。
Public Health. 2020 Dec;189:66-72. doi: 10.1016/j.puhe.2020.09.014. Epub 2020 Sep 30.
5
Predicting Mortality Due to SARS-CoV-2: A Mechanistic Score Relating Obesity and Diabetes to COVID-19 Outcomes in Mexico.预测因 SARS-CoV-2 导致的死亡率:一个将肥胖和糖尿病与墨西哥 COVID-19 结局相关联的机制评分。
J Clin Endocrinol Metab. 2020 Aug 1;105(8). doi: 10.1210/clinem/dgaa346.
6
Independent Role of Severe Obesity as a Risk Factor for COVID-19 Hospitalization: A Spanish Population-Based Cohort Study.严重肥胖作为 COVID-19 住院的独立风险因素:一项基于西班牙人群的队列研究。
Obesity (Silver Spring). 2021 Jan;29(1):29-37. doi: 10.1002/oby.23029. Epub 2020 Dec 6.
7
Association of prior metabolic and bariatric surgery with severity of coronavirus disease 2019 (COVID-19) in patients with obesity.肥胖患者既往代谢和减重手术与 2019 年冠状病毒病(COVID-19)严重程度的关联。
Surg Obes Relat Dis. 2021 Jan;17(1):208-214. doi: 10.1016/j.soard.2020.10.026. Epub 2020 Nov 23.
8
Italian SARS-CoV-2 patients in intensive care: towards an identikit for subjects at risk?意大利重症监护中的 SARS-CoV-2 患者:是否存在高危人群特征?
Eur Rev Med Pharmacol Sci. 2020 Sep;24(18):9698-9704. doi: 10.26355/eurrev_202009_23061.
9
Impact of heart failure on the clinical course and outcomes of patients hospitalized for COVID-19. Results of the Cardio-COVID-Italy multicentre study.心力衰竭对因 COVID-19 住院患者的临床病程和结局的影响。意大利 Cardio-COVID 多中心研究的结果。
Eur J Heart Fail. 2020 Dec;22(12):2238-2247. doi: 10.1002/ejhf.2052. Epub 2020 Nov 27.
10
Obesity and COVID-19 Severity in a Designated Hospital in Shenzhen, China.肥胖与 2019 年冠状病毒病严重程度在深圳市某定点医院的相关性研究
Diabetes Care. 2020 Jul;43(7):1392-1398. doi: 10.2337/dc20-0576. Epub 2020 May 14.

引用本文的文献

1
Real-World Research on Retinal Diseases Using Health Claims Database: A Narrative Review.利用健康声明数据库对视网膜疾病进行的真实世界研究:一项叙述性综述。
Diagnostics (Basel). 2024 Jul 19;14(14):1568. doi: 10.3390/diagnostics14141568.
2
Clinical and economic impact of COVID-19 on people with obesity in a Spanish cohort during the first pandemic peak.COVID-19 对西班牙队列中肥胖人群的临床和经济影响在首次大流行高峰期间。
Front Endocrinol (Lausanne). 2023 May 26;14:1146517. doi: 10.3389/fendo.2023.1146517. eCollection 2023.
3
Obesity as an independent risk factor for COVID-19 severity and mortality.
肥胖是 COVID-19 严重程度和死亡率的独立危险因素。
Cochrane Database Syst Rev. 2023 May 24;5(5):CD015201. doi: 10.1002/14651858.CD015201.
4
Impact of diabetes status and related factors on COVID-19-associated hospitalization: A nationwide retrospective cohort study of 116,370 adults with SARS-CoV-2 infection.糖尿病状况及相关因素对 COVID-19 相关住院的影响:一项针对 116370 例 SARS-CoV-2 感染成年人的全国性回顾性队列研究。
Diabetes Res Clin Pract. 2022 Dec;194:110156. doi: 10.1016/j.diabres.2022.110156. Epub 2022 Nov 15.
5
Association of Obesity With COVID-19 Severity and Mortality: An Updated Systemic Review, Meta-Analysis, and Meta-Regression.肥胖与 COVID-19 严重程度和死亡率的关联:一项更新的系统评价、荟萃分析和荟萃回归研究。
Front Endocrinol (Lausanne). 2022 Jun 3;13:780872. doi: 10.3389/fendo.2022.780872. eCollection 2022.
6
Leptin as a potential prognostic marker of the severity of COVID-19 infection in obese patients.瘦素作为肥胖患者新冠病毒感染严重程度的潜在预后标志物。
Nutr Metab Cardiovasc Dis. 2022 Mar;32(3):743-744. doi: 10.1016/j.numecd.2021.12.003. Epub 2021 Dec 10.
7
Proof-of-concept trial of an amniotic fluid-derived extracellular vesicle biologic for treating high risk patients with mild-to-moderate acute COVID-19 infection.一种源自羊水的细胞外囊泡生物制剂用于治疗轻至中度急性COVID-19感染高危患者的概念验证试验。
Biomater Biosyst. 2021 Dec;4:100031. doi: 10.1016/j.bbiosy.2021.100031. Epub 2021 Nov 24.
8
Innate Immunity in Children and the Role of ACE2 Expression in SARS-CoV-2 Infection.儿童的先天免疫以及ACE2表达在SARS-CoV-2感染中的作用
Pediatr Rep. 2021 Jul 2;13(3):363-382. doi: 10.3390/pediatric13030045.